Company intelligence / Profile preview

Thorne BioScience

New York, New York, United States

Ownership: Private
Employees: ~700
Development stage: Other

Overview

Thorne HealthTech is a science-driven wellness company that provides a vertically integrated platform for personalized health solutions. The company utilizes advanced testing and data analytics, specifically through its Onegevity AI platform, to deliver insights and high-quality nutritional supplements. Thorne focuses on various health areas including aging, performance, and metabolic health, serving consumers, professional athletes, and healthcare practitioners. In 2023, the company was acquired by L Catterton and transitioned from a public entity to a private one.

Therapeutic areas: NeurologyOtherMetabolic Disorders
Modalities: Small moleculePeptidesProbioticsNutritional supplements
Industry: Food & Nutrition

Partnerships

Mayo ClinicUFCUSA TriathlonMitsui & Co.

Beyond the preview

Go deeper on Thorne BioScience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thorne BioScience.

Explore the full profile